Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study

被引：0
|
作者：
Andrea Chiricozzi
Niccolò Gori
Alessandra Narcisi
Anna Balato
Alessio Gambardella
Michela Ortoncelli
Angelo Valerio Marzano
Riccardo Balestri
Giovanni Palazzo
Michele Pellegrino
Marco Romanelli
Giovanni Tripepi
Ketty Peris
Antonio Costanzo
机构：
[1] Fondazione Policlinico Universitario A. Gemelli-IRCCS,UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche
[2] Università Cattolica del Sacro Cuore,Dermatologia, Dipartimento di Medicina e Chirurgia Traslazionale
[3] Humanitas University,Dermatology, Department of Biomedical Sciences
[4] IRCCS Humanitas Research Hospital,Skin Pathology Laboratory
[5] University of Campania Luigi Vanvitelli,Dermatology Unit
[6] University of Turin,Medical Sciences Department, Dermatologic Clinic
[7] Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico,Dermatology Unit
[8] Università degli Studi di Milano,Department of Pathophysiology and Transplantation
[9] Santa Chiara Hospital,Division of Dermatology
[10] Ospedale distrettuale “A. Lo Dico”,Dermatology
[11] Misericordia Hospital,Dermatology Unit
[12] University of Pisa,Department of Dermatology
[13] Sede di Reggio Calabria,Istituto di Fisiologia Clinica del CNR
[14] Ospedale Civile SS. Giovanni e Polo,Section of Dermatology, Department of Clinical Medicine and Surgery
[15] University of Naples Federico II,Dermatology, Department of Biotechnological and Applied Clinical Sciences
[16] University of L’Aquila,Section of Dermatology and Venereology, Department of Medicine
[17] University of Verona,Department of Health and Science (Dissal), Section of Dermatology
[18] University of Genoa,undefined
[19] Polyclinic Hospital San Martino,undefined
[20] IRCCS,undefined
来源：
Drugs in R&D | 2022年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：245 / 252
页数：7
相关论文
共 50 条
  • [1] Effectiveness and Safety of Upadacitinib in the Treatment of Moderate-Severe Atopic Dermatitis: A Multicentric, Prospective, Real-World, Cohort Study
    Chiricozzi, Andrea
    Gori, Niccolo
    Narcisi, Alessandra
    Balato, Anna
    Gambardella, Alessio
    Ortoncelli, Michela
    Marzano, Angelo Valerio
    Balestri, Riccardo
    Palazzo, Giovanni
    Pellegrino, Michele
    Romanelli, Marco
    Tripepi, Giovanni
    Peris, Ketty
    Costanzo, Antonio
    [J]. DRUGS IN R&D, 2022, 22 (03) : 245 - 252
  • [2] The efficacy and safety of upadacitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan
    Hagino, Teppei
    Saeki, Hidehisa
    Kanda, Naoko
    [J]. JOURNAL OF DERMATOLOGY, 2022, 49 (11): : 1158 - 1167
  • [3] Upadacitinib for the treatment of moderate-to-severe atopic dermatitis in real-world clinical practice
    Tran, Vanessa
    Ross, Gayle
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 11 - 11
  • [4] Effectiveness and safety of upadacitinib for moderate-to-severe atopic dermatitis in a real-world setting: A 52-week retrospective study
    Gargiulo, L.
    Ibba, L.
    Piscazzi, F.
    Alfano, A.
    Ingurgio, R. Cascio
    Valenti, M.
    Costanzo, A.
    Narcisi, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (02) : e152 - e154
  • [5] Effectiveness and Safety of Upadacitinib for Adolescents with Atopic Dermatitis in a Real-World Setting
    Patruno, Cataldo
    Lauletta, Giuseppe
    Pezzolo, Elena
    Boccaletti, Valeria
    Rossi, Mariateresa
    Caroppo, Francesca
    Fortina, Anna Belloni
    Russo, Filomena
    Cocuroccia, Barbara
    Dal Bello, Giacomo
    Martora, Fabrizio
    di Vico, Francesca
    Napolitano, Maddalena
    [J]. CLINICAL DRUG INVESTIGATION, 2024, 44 (08) : 629 - 634
  • [6] Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study
    Hagino, Teppei
    Hamada, Risa
    Yoshida, Mai
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    [J]. PHARMACEUTICALS, 2024, 17 (04)
  • [7] Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
    Hagino, Teppei
    Saeki, Hidehisa
    Fujimoto, Eita
    Kanda, Naoko
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
  • [8] A real-world Australian experience of upadacitinib for the treatment of severe atopic dermatitis
    Tran, Vanessa
    Ross, Gayle
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 (04) : e352 - e356
  • [9] Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders
    Zhao, Mutong
    Zhuang, Yi
    Liang, Yuan
    Ma, Lin
    Shen, Chunping
    [J]. CLINICAL AND EXPERIMENTAL ALLERGY, 2024,
  • [10] Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: A multi centric retrospective study
    Dhar, Sandipan
    De, Abhishek
    Srinivas, Sahana M.
    [J]. INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 297 - 301
12345